Edoc Acquisition Corp.

Status: Deal Closed

U=S+W+R W=S/2@11.5 R=S/10

IPO Proceeds, $M	$90.00M
IPO Date	Nov 10, 2020
CEO	Kevin Chen
Left Lead	I-Bankers Securities
IPO Cash in Trust	101.7%
SPAC Tenor	12 + 3 + 6 + 6 + 6 + 3 + 6
IPO Sector	Healthcare Healthcare and healthcare providers in North America and Asia-Pacific
IPO Geography	Global
Target Company	Australian Oilseeds Investments
Deal Announced	Dec 7, 2022
Deal Size, $M	$190.00M
Deal Sector	Food
Deal Geography	EEMEA
SEC Filings	www.sec.gov
Approval Vote	Mar 5, 2024
Amendment Vote	Nov 6, 2023
Closing Date	Mar 21, 2024

Formerly ADOC COOT COOTW

Price	$0.94
Last closing price	$0.86
Volume, today	1,071
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.02
Last closing price	$0.03
Volume, today	430
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

No credit card required

Structure and cap table
5 directors & officers
58 filings and events
3 underwriters
3 deal advisors
4 legal advisors

Structure

Sign in to view structure, cap table, and calendar of events.

Team

Name	Age	Title
Kevin Chen	43	Chairman and CEO
Bob Ai	57	CFO and Director
Gang Li	49	Director
Yan Michael Li	50	Director
Jintao Zheng	46	Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors

Underwriters

I-Bankers Securities	BR	8,050,000	units
Ingalls & Snyder		900,000
B. Riley FBR		50,000
		9,000,000	units
Up-Front UW fee		1.75	%
BCMA		2.75	%

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings


Sep 15, 2020	Initial S-1
Oct 19, 2020	S-1/A Amendment #1 Sign In to view filing content.
Oct 27, 2020	S-1/A Amendment #2 Sign In to view filing content.
Nov 2, 2020	S-1/A Amendment #3 Sign In to view filing content.
Nov 6, 2020	S-1/A Amendment #4 Sign In to view filing content.
Nov 10, 2020	PR announcing pricing of downsized $90mm IPO Sign In to view filing content.
Nov 12, 2020	424B4 IPO Prospectus
Dec 15, 2020	8-K announcing separate trading of common stock, warrants, and rights Sign In to view filing content.
Jan 5, 2021	8-K with director waiver letter Sign In to view filing content.
Nov 9, 2021	8-K announcing sponsor contribution to trust in connection with extension Sign In to view filing content.
Nov 15, 2021	8-K announcing sponsor contribution to trust in connection with extension Sign In to view filing content.
Jan 13, 2022	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Jan 24, 2022	DEF14A Definitive proxy for charter extension meeting Sign In to view filing content.
Feb 2, 2022	8-K announcing business combination with Calidi Biotherapeutics Sign In to view filing content.
Feb 4, 2022	DEFA14A with amendment to Calidi merger agreement Sign In to view filing content.
Feb 7, 2022	8-K/A with full Calidi Biotherapeutics merger agreement Sign In to view filing content.
Feb 14, 2022	8-K with extension meeting results and amendment #1 to Calidi business combination Sign In to view filing content.
Mar 17, 2022	S-4 registration statement containing preliminary proxy for Calidi business combination Sign In to view filing content.
Mar 17, 2022	8-K with Amendment to Securities Purchase Agreement and Common Stock Purchase Agreement Sign In to view filing content.
May 24, 2022	425 with update on intended merger target - Calidi Sign In to view filing content.
May 25, 2022	8-K with Amendment #2 to Calidi merger agreement Sign In to view filing content.
May 26, 2022	S-4/A Amendment #1 to registration statement containing preliminary proxy for Calidi business combination Sign In to view filing content.
Jun 28, 2022	425 with update in Calidi's management Sign In to view filing content.
Jul 15, 2022	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Jul 25, 2022	PRER14A Revised preliminary proxy for charter extension meeting Sign In to view filing content.
Jul 28, 2022	DEF14A Definitive proxy for charter extension meeting Sign In to view filing content.
Aug 4, 2022	8-K announcing change in sponsor contribution for extension Sign In to view filing content.
Aug 12, 2022	8-K announcing postponement of extension meeting Sign In to view filing content.
Aug 12, 2022	8-K announcing termination of Calidi Biotherapeutics business combination Sign In to view filing content.
Aug 15, 2022	8-K with extension meeting results Sign In to view filing content.
Oct 6, 2022	8-K announcing change in Directors Sign In to view filing content.
Oct 18, 2022	8-K announcing notice of delisting from the NASDAQ and change in directors Sign In to view filing content.
Dec 7, 2022	8-K announcing business combination with Australian Oilseeds Investments Sign In to view filing content.
Dec 9, 2022	8-K with full Australian Oilseeds Investments merger agreement Sign In to view filing content.
Jan 6, 2023	PRE14A Preliminary proxy for charter extension meeting Sign In to view filing content.
Jan 25, 2023	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Feb 15, 2023	8-K with extension meeting results Sign In to view filing content.
Mar 9, 2023	8-K announcing conversion of backstop and sponsor shares Sign In to view filing content.
Apr 6, 2023	8-K with Amendment #1 to Australian Oilseeds Investments merger agreement Sign In to view filing content.
Jul 13, 2023	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Jul 27, 2023	DEF14A Definitive proxy for charter extension meeting Sign In to view filing content.
Aug 16, 2023	8-K with extension meeting results Sign In to view filing content.
Aug 24, 2023	8-K announcing $7mm PIPE and a $50mm equity line of credit Sign In to view filing content.
Sep 18, 2023	F-4 registration statement containing preliminary proxy for Australian Oilseeds Investments business combination Sign In to view filing content.
Oct 3, 2023	PRE14A Preliminary Proxy for charter extension meeting Sign In to view filing content.
Oct 16, 2023	DEF14A Definitive Proxy for charter extension meeting Sign In to view filing content.
Nov 3, 2023	8-K announcing sponsor forfeiture Sign In to view filing content.
Nov 13, 2023	8-K with extension meeting results Sign In to view filing content.
Dec 7, 2023	8-K with Amendment #2 to Australian Oilseeds Investments merger agreement Sign In to view filing content.
Dec 8, 2023	F-4/A Amendment #1 to registration statement containing preliminary proxy for Australian Oilseeds Investments business combination Sign In to view filing content.
Jan 17, 2024	F-4/A Amendment #2 to registration statement containing preliminary proxy for Australian Oilseeds Investments business combination Sign In to view filing content.
Jan 30, 2024	F-4/A Amendment #3 to registration statement containing preliminary proxy for Australian Oilseeds Investments business combination
Feb 7, 2024	424B3 Definitive proxy for Australian Oilseeds Investments business combination Sign In to view filing content.
Feb 23, 2024	PR announcing postponement Australian Oilseeds Investments business combination Sign In to view filing content.
Feb 27, 2024	8-K announcing postponement Australian Oilseeds Investments business combination Sign In to view filing content.
Mar 1, 2024	8-K with Amendment #3 to Australian Oilseeds Investments merger agreement Sign In to view filing content.
Mar 11, 2024	8-K with Australian Oilseeds Investments meeting results Sign In to view filing content.
Mar 21, 2024	CA Corporate Action Alert announcing closing of Australian Oilseeds business combination Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.